O Brien Greene & Co. Inc Boosts Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

O Brien Greene & Co. Inc increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.2% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 723 shares of the healthcare conglomerate’s stock after buying an additional 61 shares during the period. O Brien Greene & Co. Inc’s holdings in UnitedHealth Group were worth $366,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $30,000. RPg Family Wealth Advisory LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth $37,000. DecisionPoint Financial LLC lifted its holdings in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares during the last quarter. Highline Wealth Partners LLC bought a new position in UnitedHealth Group in the third quarter valued at $55,000. Finally, Legacy Investment Solutions LLC bought a new stake in UnitedHealth Group during the third quarter worth about $57,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $510.75 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $470.03 billion, a price-to-earnings ratio of 32.95, a PEG ratio of 1.37 and a beta of 0.61. The business’s fifty day moving average is $520.62 and its 200 day moving average is $561.67. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the company posted $5.83 EPS. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on UNH shares. Piper Sandler dropped their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Finally, Oppenheimer lifted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.